From Meta AI security vulnerabilities to the emergence of massive 10,000mAh battery phones and Nvidia's RTX Spark, we analyze the current volatility in the tech market.
CEPI has allocated $50 million to Moderna to accelerate an mRNA vaccine for the Bundibugyo ebolavirus as an outbreak surges in the DRC.
The NIAID, once led by Anthony Fauci, faces a critical leadership void as new Ebola outbreaks emerge, raising questions about the US's readiness for the next pandemic.
The U.S. government is accelerating mRNA vaccine development for the Bundibugyo virus as Ebola outbreaks persist, granting Moderna $50 million for rapid prototyping.
An analysis of the recurring patterns of vaccine opposition, from 18th-century smallpox inoculation to modern digital misinformation.
New clinical trial data reveals a personalized mRNA vaccine from Moderna significantly reduces the risk of melanoma returning and metastasizing over five years.
The National Institute of Allergy and Infectious Diseases (NIAID) remains without a permanent director as global Ebola threats rise, raising questions about U.S. pandemic readiness.
From 18th-century smallpox pushback to modern digital skepticism, the arguments against vaccines aren't new—they're a repeating cycle of misinformation.
Scientists at Memorial University of Newfoundland have discovered that severed appendages from the Psolus fabricii sea cucumber can survive and reorganize indefinitely in seawater.
NASA's aggressive timeline for a permanent lunar base by 2030 relies on a new 'Science as a Service' model, but critical health and biological risks remain unfunded.